3 “Compelling, But Affordable” Biotech Names For A Bullish View Of The Market
In a bullish take on current circumstances, Morgan Stanley’s head of U.S. equity strategy argued in a recent note to clients that the current state…
Market
3 Top Stock Picks From The “Recession-Proof” Biotech Sector
It should come as no surprise that one of the top biotech stocks to consider right now, as identified by the author of today’s article,…
Upside Potential In The Pipelines: 3 “Strong Buy” Biotech Stocks To Consider
Some sectors are holding up much better than others in the current market environment – and offering compelling plays in the process. One of those…
2 Top Picks From “The Rest Of The Biopharma Industry”
While most of the attention in the biotech space is currently focused on companies working on potential vaccines for the novel coronavirus and treatments for…
Reflections On “The Worst Day Of Our Investment Lives”
Although it was only the 7th worst daily return since 1950, the author of today’s article declares that, for many, March 9, 2020 was the…
Checking Up On Potential Coronavirus Treatment/Vaccine Plays
While there are currently no FDA-approved vaccines or therapeutics for it, today’s article notes that “A mix of legacy drugmakers and small startups have stepped…
5 “Alternative” ETFs To Protect Against Losses – Or Make Money – Amid The Market Mayhem
For those investing for the long-term, the best thing to do in response to current market turmoil, driven by fears surrounding the novel coronavirus, may…
A Dozen Stocks With Attractive Growth AND Value Characteristics
Growth stocks have been the better performers in recent years. Meanwhile, when it comes to value investing, some have declared value dead, while others believe…
Epidemics, Pandemics & Portfolios
When it comes to the panic surrounding the novel coronavirus, the author of today’s article states “Because I am not an epidemiologist, I won’t opine…
Time’s Not Up For Tech
For investors who see concerning parallels between the recent run-up in tech stocks and the dot-com bubble of the late 1990s/early 2000s, a recent analysis…